We will look at the state of health and life sciences in the Bay Area, with a view to how and where this sector will grow in our region. We will explore the intersection of health and life science, the impact of AI and other technology, and how companies are making decision on where and how to manufacture and where they will grow their operations. What is the climate for startups and innovation in the coming years? How well is our region meeting the needs for a diverse workforce? And what are some innovative approaches, and industry stance on drug pricing?
Keynote Q&A Speakers:
MARIA T. MILLAN, M.D.
President & CEO, California Institute for Regenerative Medicine
MATTHEW GARDNER
Americas Life Sciences Leader, Advisory | CBRE
PAUL HASTINGS
President & CEO, Nkarta Therapeutics
CHRIS HASKELL, PH.D.
Regional Head, JLABS@San Francisco Bay Area, Johnson & Johnson Innovation I JLABS
DR. JENS VOGEL
SVP & Global Head of Biotech, Bayer Pharmaceuticals
